Orthopaedic prostheses greatly improve the quality of life for many individuals that suffer bone loss due to disease or a congenital abnormality. The success of these devices is dependent upon the body's ability to synthesize new bone in direct apposition to the implant surface. In consequence, considerable research effort has been directed at understanding the factors that promote the association of bone cells with implants. This association, like most cell/matrix interactions, is thought to be directed by the integrin family of cell adhesion receptors. In tandem with mediating cell attachment, integrins appear to play a role in regulating the differentiation of bone precursor cells, an event that is prerequisite for new bone synthesis. Studies of prostheses that have been retrieved from laboratory animals suggest that devices coated with synthetic bone analogue, hydroxyapatite, have substantially more bony in-growth than uncoated metal implants. A central hypothesis is therefore proposed that hydroxyapatite is superior to titanium to promoting integrin-mediated osteoblast attachment and differentiation. Preliminary data from our laboratory reveal that purified integrins do, indeed, bind better to serum-coated hydroxyapatite than to serum-coated titanium. Moreover, integrin ligands within serum adsorb preferentially to hydroxyapatite, thus enhanced integrin binding is likely due to the increased concentration of ligand at the hydroxyapatite surface. Finally, osteoblast precursor cells, similar to purified integrins, demonstrate markedly better binding to hydroxyapatite than to precursors and implant biomaterials. As part of Specific Aim 1, we will identify the specific integrins and integrin will examine the events downstream of integrin activation, such as tyrosine kinase-mediated signal transduction, cytoskeletal reorganization and extracellular matrix assembly. Finally, in Specific Aim 3, osteoblasts grown on either hydroxyapatite or titanium will be evaluated or differentiation, as measured by the expression of differentiation-specific proteins, as well as by mineralization assays. Collectively these experiments will provide important insight into the cellular and molecular mechanisms that contribute to the enhanced bone- ingrowth that has been observed with hydroxyapatite-coated implants, relative to uncoated metal devices.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
1P30AR046031-01A1
Application #
6459324
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2001-05-01
Project End
2006-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Chen, Wei; Zhu, Guochun; Tang, Jun et al. (2018) C/ebp? controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1. J Pathol 244:271-282
Chen, Wei; Zhu, Guochun; Jules, Joel et al. (2018) Monocyte-Specific Knockout of C/ebp? Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebp? in Osteoclast Differentiation and Function. J Bone Miner Res 33:691-703
Jules, Joel; Chen, Wei; Feng, Xu et al. (2018) C/EBP? transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos. J Biol Chem 293:1480-1492
Wu, Mengrui; Wang, Yiping; Shao, Jian-Zhong et al. (2017) Cbf? governs osteoblast-adipocyte lineage commitment through enhancing ?-catenin signaling and suppressing adipogenesis gene expression. Proc Natl Acad Sci U S A 114:10119-10124
Cai, Xiaofeng; Xing, Junjie; Long, Courtney L et al. (2017) DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis. J Bone Miner Res 32:2207-2218
Jules, Joel; Chen, Wei; Feng, Xu et al. (2016) CCAAT/Enhancer-binding Protein ? (C/EBP?) Is Important for Osteoclast Differentiation and Activity. J Biol Chem 291:16390-403
Levy, Seth; Feduska, Joseph M; Sawant, Anandi et al. (2016) Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade. Bone 93:113-124
Higgs, Jerome T; Jarboe, John S; Lee, Joo Hyoung et al. (2015) Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. Mol Cancer Res 13:819-27
Li, Sheng; Hao, Liang; Wang, Lin et al. (2015) Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology. PLoS One 10:e0134903
Deshane, Jessy S; Redden, David T; Zeng, Meiqin et al. (2015) Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease. J Allergy Clin Immunol 135:413-424.e15

Showing the most recent 10 out of 138 publications